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Abstract: Fish oil and conjugated linoleic acid (CLA) belong to a popular class of food 
supplements known as “fat supplements”, which are claimed to reduce muscle glycogen 
breakdown, reduce body mass, as well as reduce muscle damage and inflammatory 
responses. Sport athletes consume fish oil and CLA mainly to increase lean body mass and 
reduce body fat. Recent evidence indicates that this kind of supplementation may have 
other side-effects and a new role has been identified in steroidogenensis. Preliminary 
findings demonstrate that fish oil and CLA may induce a physiological increase in 
testosterone synthesis. The aim of this review is to describe the effects of fish oil and CLA 
on physical performance (endurance and resistance exercise), and highlight the new results 
on the effects on testosterone biosynthesis. In view of these new data, we can hypothesize 
that fat supplements may improve the anabolic effect of exercise. 
Keywords: fish oil; conjugated linoleic acid; endurance exercise; resistance exercise; 
steroidogenic cells; steroidogenesis; testosterone 
 
1. Introduction 
Many food supplements claim to induce weight loss by increasing lean body mass or reducing body 
fat mass, although only a few of these ergogenic aids have been investigated [1]. This review focuses 
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on a popular class of food supplements known as “fat supplements”, which are marketed with claims 
to induce weight loss, alter lipid profiles, improve performance, increase fat metabolism and spare 
glycogen stores during endurance exercise [2]. 
The class of commercially available fat supplements includes conjugated linoleic acid (CLA), fish 
oil, long- and medium-chain triacylglycerols. These ergogenic aids are claimed to be associated with a 
reduction in muscle glycogen breakdown, improved endurance capacity, reduced body mass and a 
reduction in muscle damage and inflammatory responses [2]. Only two fat supplements have been 
shown to affect testosterone biosynthesis: fish oil and CLA. 
Fish oil contains both the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic 
acid (EPA). They are polyunsaturated fatty acids (PUFA) with a double carbon bond starting after the 
third carbon atom from the end of the carbon chain [3]. The main source of omega-3 fatty acids is fish 
(such as tuna and salmon), although fish do not produce omega-3 fatty acids, they accumulate them by 
consuming either microalgae or fish that have a large quantity of omega-3 fatty acids. Food integration 
with DHA and EPA seems to reduce the incidence of cardiovascular diseases [4,5], reduce the release 
of inflammatory acute-phase proteins [6,7], and reduce superoxide anion production from stimulated 
blood neutrophils [8], although an old epidemiologic study stated that fish oil did not lower the risk of 
cardiovascular disease [9]. 
The CLA supplement is a mixture of positional and geometrical conjugated dienoic isomers of 
linoleic acid which present two double bonds separated by a single bond [10]. These double bonds can 
be located in any position of the carbon chain, commonly between 8 and 13, and in a cis or trans 
configuration. The two most common isomers of CLA are cis-9, trans-11 and trans-10, cis-12 (c9:t11 
and t10:c12, respectively) [10,11]. The major sources of CLA in human diets are ruminant meats (beef 
and lamb) and dairy products (milk and cheese) [12]. It has been reported that CLA has anti-obesity 
potentials, such as decreasing lipogenesis and food intake, and increasing energy expenditure, lipolysis 
and fat oxidation [13,14]. 
Recent results suggest a new role of this class of supplementation in testosterone biosynthetic 
pathways. This review describes the various fat supplements pointing out both the known effects 
produced by these supplements when associated with exercise, and the new data underlying the 
molecular mechanisms regulating testosterone biosynthesis. Finally, it is briefly described how these 
fat supplements may influence physical performance. This review focuses mainly on human studies, 
although animal and in vitro studies have been cited whenever the information is not available 
in humans.  
Potential studies were identified by searching electronic databases: PubMed, Cochrane, and Scopus. 
The search terms used included both single words and combinations of words: CLA, fish oil, 
testosterone, exercise. Bibliographies were checked and experts were consulted for any additional 
studies. Studies available as full papers were deemed eligible if they conformed to the predetermined 
inclusion and exclusion criteria (Figure 1). 
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Figure 1. Methodological procedure of literature research. 
 
2. Association of Exercise and Fat Supplements 
Elite and recreational athletes, who participate in various types of physical activity and sports, 
consume fish oils and CLA supplements to improve their performance, increase training effects, 
reduce body fat, increase lean body mass, and reduce muscle damage and inflammatory responses. The 
following paragraph summarizes the main results obtained from trained individuals after integration 
with fish oil (Table 1) or CLA (Table 2), comparing these results with the ones obtained in animal 
studies. All of the studies that have investigated the effects of these fat supplements in combination 
with other food supplements have not been cited, since it was impossible to isolate the single effect of 
fish oil or CLA. 
Only a few studies have examined whether fish oil supplementation during training enhances 
endurance adaptations. These studies conducted in humans show controversial results, but in our 
opinion this is due to the difference in the level of training of the study participants. In elite or  
well-trained athletes, the margin of improvement is so inappreciable that it would not be a surprise if 
small differences in performance parameters were observed; while in sedentary subjects, starting a 
training program, the improvement in performance is considerable, making a possible small 
enhancement in performance induced by food supplementation undetectable. Therefore the most 
reliable results have been observed in trained subjects, who already show adaptations for that specific 
type of exercise, although still improving their performance. 
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Oostenbrug et al. [15] D–R–P Cyclist 
(24, M) 
Acute aerobic bout  
(60 min time trial) 
3 weeks  
(6 g/day) 
 No effect: endurance performance 
Buckley et al. [16] D–R–P Australian rules 
football players 
(25, M) 
Acute aerobic bout to 
exhaustion 
5 weeks  
(6 g/day) 
 No effect: endurance performance, 
recovery; 
 Improve: CV function 






 No effect: maximal aerobic power, 
anaerobic power, performance 
Peoples et al. [18] D–R–P Cyclist 
(16, M) 
Acute aerobic bout  
(50% of peak workload) 
8 weeks  
(8 g/day) 
 No effect: endurance performance; 
 Reduce: whole-body and myocardial 
O2 demand 
Brilla et al. [19] D–R Sedentary 
(32, M) 
60 min (3 day/week) 
aerobic exercise 
10 weeks  
(4 g/day) 
 No effect: Body composition; 
 Improve: VO2max, VAT 
Guezennec et al. [20] D–R–P Healthy 
(14, M) 
Acute aerobic bout  
(60 min 70% of VO2max) 
6 weeks  
(6 g/day) 
 Improve: VO2max, RBC deformability 
Ernst et al. [21] D Healthy 
(14, M) 
Acute aerobic bout 3 weeks 
(2.8 g/day) 
 Reduce: inflammatory acute-phase 
response 
Toft et al. [22] D–R Runners 
(20, M) 
Marathon 6 weeks 
(2.8 g/day) 
 No effect: inflammatory acute-phase 
response 
Lenn et al. [23] D–R–P Healthy 
(22, M) 
50 Maximal eccentric 
elbow flexion contractions 
30 days  
(1.8 g/day) 
 No effect: inflammatory acute-phase 
response 
Abbreviations present in the table: D, double-blind; R, randomised; P, placebo-controlled; M, male; CV, cardiovascular; 
VAT, ventilatory aerobic threshold; RBC, red blood cells. 











Zambell et at. [14] D–R–P 
Healthy 
(17, F) 
Acute aerobic bout 
(walking) 
64 days  
(3 g/day) 
 No effect: energy expenditure, 
RER, Fat oxidation 





4 weeks  
(6 g/day) 
 No effect: Body composition, bone 
density, strength 
Lambert et al. [25] D–R–P 
Physically active 





 No effect: Body composition, RER 
Macaluso et al. [26] D–R–P–C 
Physically active 
(10, M) 
Resistance training +  
Acute resistance bout 
3 weeks  
(6 g/day) 
 No effect: Body composition; 
 Slight increase total testosterone 
Thom et al. [27] D–R–P 
Physically active 
(10, M; 10, F) 




 Improve: Body composition, 
endurance performance 
Colakoglu et al. [28] D–R–P–C 
Healthy 
(44, F) 




 Improve: Body composition, 
endurance performance 
Pinkoski et al. [29] D–R–P 
Healthy 
(17, F) 
90 min (3 day/week) 
Resistance exercise 
7 weeks  
(5 g/day) 
 Improve: Body composition 
Abbreviations present in the table: CLA, conjugated linoleic acid; D, double-blind; R, randomised; P, placebo-controlled; 
C, crossover; M, male; F, female; RER, respiratory exchange ratio. 
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One of the effects claimed by fish oil is the ability to modify the viscosity of the plasma membrane 
of red blood cells (RBC), improving their deformability when they pass through the capillary  
bed [30–32]. Alterations in lipid membrane physical features probably depend on the integration and 
enrichment of omega-3 fatty acids [32]. The first studies were performed on healthy humans [30] and 
angina patients [31], later on it was hypothesized that, in the same way, fish oil could enhance oxygen 
delivery to contracting muscle and maximum oxygen uptake (VO2max), thus improving endurance 
performance [2]. It was observed that endurance exercise itself increases the fraction of PUFA in 
muscle membranes [33]. 
However, literary data are controversial. Oostenbrug et al. [15] studied the effects of three weeks 
fish oil feeding (6 g/day) and observed a small not significant decrease (2%) in RBC deformability, 
which appears unlikely to affect VO2max or exercise performance of well-trained cyclists [15]. Others 
observed that fish oil supplementation does not improve exercise performance of elite athletes 
practicing different sports (elite Australian rules footballers [16], well-trained soccer players [17]). 
Fish oil reduces both whole-body and myocardial oxygen demand during exercise, without affecting 
performance [18]. Sedentary males supplemented with fish oil for 10 weeks (4 g/day) and exercised 
three times per week, had no additional effect on VO2max compared to only training effect, although the 
supplemented exercised subjects and the supplemented non-exercised subjects showed an increase in 
the ventilatory aerobic threshold compared to the control [19].  
The most significant documented results were observed in fit male subjects supplemented with fish 
oil (6 g/day) for six weeks [20]. Fish oil feeding increased the fraction of omega-3 fatty acids in RBC 
membranes, increasing their deformability during hypobaric exercise; VO2max increased significantly 
and O2 desaturation rate decreased as an effect of fish oil supplementation [20]. 
The extensive literature on the effect of omega-3 supplementation also provides evidence that fish 
oil is effective in the prevention and treatment of inflammatory conditions [34]. It was hypothesized 
that fish oil supplementation may prevent secondary muscle damage induced by an acute inflammatory 
response in reaction to tissue damage caused by a bout of intense exercise. Inflammation and 
inflammatory responses are maintained in the muscle tissue by local and systemic elevation of specific 
cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). Controversial results are 
reported in the literature on the effects of fish oil supplementation in reducing the inflammatory 
response and delayed-onset muscle soreness, following acute exercise. Ernst et al. [31] have shown a 
reduction in the rise of acute-phase proteins, associated with the inflammatory response, in healthy 
males after three weeks of omega-3 supplementation (3.80 g/day). No difference in blood levels of 
TNF-α and IL-6 were observed in runners after a marathon run and in sedentary subjects following 
maximal isokinetic eccentric elbow-flexor contractions supplemented with fish oil (3.6 g/day for six 
weeks, 1.8 g/day for six weeks; respectively) [22,23]. Nieman et al. [35] also showed that n-3 PUFA 
somministration did not alter inflammatory proteins and plasma cytokines. The results on secondary 
muscle damage induced by an acute inflammatory response are extremely interesting, and more 
research is needed before conclusions can be drawn on fish oil supplementation in trained individuals. 
Omega-3 supplementation may provide benefits by minimizing the recovery time between exercise 
sessions reducing the inflammatory response localized in muscle tissue as well as the associated 
delayed-onset of muscle soreness. 
Nutrients 2013, 5 514 
 
CLA supplementation may induce a reduction in body weight, this statement is based on results 
obtained in humans and in animals, even if the effect on humans is less clear than in animals. In many 
studies CLA supplementation was not associated with any regular and supervised physical activity. 
Only six studies have been conducted to evaluate the effect of CLA supplementation associated with 
exercise. Kreider et al. [24] investigating the effects of CLA supplementation for four weeks (6 g/day) 
in bodybuilders concluding that CLA does not appear to possess any significant ergogenic value, since 
no differences were observed in body composition and strength at the end of the supplementation 
period. No change in body composition was observed by Lambert et al. [25] after CLA 
supplementation. The study was conducted using regular non-obese exercising men and woman 
integrated with CLA (3.9 g/day) for 12 weeks. Similar results have been reported by our research 
group, in a study performed with regularly exercising men integrated with CLA (6 g/day) for four 
weeks [26]. On the contrary other studies demonstrated a significant reduction in body fat but not body 
weight in men upon CLA supplementation. The study of Thom et al. [27] where men and women were 
supplemented with 1.8 g/day CLA for 12 weeks combined with a standardized physical exercise 
protocol of 90 min three times per week, and the study of Colakoglu et al. [28] showed that both 
3.6 g/day CLA for six weeks and exercise (30 min, 3 days per week, for 6 weeks) are effective in 
improving endurance performance and body composition. A small effect was determined by  
Pinkoski et al. [29] who studied the effects of CLA supplementation during resistance exercise; they 
performed a cross over study where subjects were randomized to receive CLA (5 g/day) or placebo for 
seven weeks while performing resistance training three days per week. 
We can conclude that CLA supplementation, associated with resistance training, results in an 
increase in lean body mass and a decrease in body fat mass only when the subjects are involved in 
standardized and supervised exercise sessions during the supplementation period. 
3. Testosterone Biosynthesis 
In males testosterone is mainly (>95%) synthesized in Leydig cells. Testosterone biosynthesis 
follows an enzymatic sequence of steps from de novo synthesized cholesterol, either intracellular 
cholesterol esters or extracellular supplies from circulating low-density lipoproteins. Cholesterol is 
converted to pregnenolone by P450-linked side-chain cleaving enzyme (P450ssc), an inner-membrane 
protein of mitochondria, that catalyzes the cleavage reaction. Pregnenolone may be converted to 
progesterone by 3β-hydroxysteroid dehydrogenase (3β-HSD), located in both mitochondria and 
smooth endoplasmic reticulum, or to 17α-hydroxy pregnenolone by 17α-hydroxylase/17,20-lyase 
(P450c17). Progesterone may be converted to 17α-hydroxy progesterone, androstenedione and finally 
to testosterone. Pregnenolone may be converted to 17α-hydroxy pregnenolone, dehydroepiandrosterone, 
androstenediol and testosterone, or it may be converted to progesterone derivates entering a  
different pathway. 
Figure 2 is a schematic representation of the enzymatic sequence of testosterone biosynthesis, 
starting from cholesterol. For an excellent review on testosterone biosynthesis and enzymes involved 
in the pathway, the reader is referred to a review by Ye et al. [36]. 
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Figure 2. Potential effects of fat supplements and exercise on testosterone biosynthesis. 
The hydroxylase enzymes involved in the synthesis of testosterone have a nomenclature 
that indicates the site of hydroxylation (e.g., 17α-hydroxylase introduces a hydroxyl group 
to carbon 17) or the site of hydroxylation in addition to being identified as P450 class 
enzymes (e.g., the 17α-hydroxylase is also identified as P450c17). The officially preferred 
nomenclature for the cytochrome P450 class of enzymes is to use the prefix CYP  
(e.g., 17α-hydroxylase should be identified as CYP17A1). The symbols + and − indicate 
the over or the under expression of a specific enzyme or hormone stimulated by one of the 
conditions indicated with different colors (red: fish oil supplementation; green: CLA 
supplementation; black: resistance exercise; purple: moderate prolonged endurance exercise). 
 
4. Effects of Fat Supplementation on Testosterone Biosynthesis 
A new role of fat supplements is starting to be delineated in the scientific community, although the 
results have been mainly obtained in animals or in vitro studies. In fact, it has been shown that dietary 
fat improves reproductive performance although the molecular mechanism has not yet been elucidated. 
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Among the different theories, there is one that hypothesizes that dietary fat may directly increase 
steroidogenesis [37] or directly alter the receptor composition of the testicular plasma  
membranes [38,39].  
Castellano et al. [40], studying the effect of long-term omega-6 fatty acids supplementation on 
steroid production of healthy adult pigs, showed that, regardless of the EPA/DHA ratio, fish oil 
supplementation modified the fatty acid composition in testis affecting the testicular concentration of 
testosterone. Similar results have been obtained in vitro using the H295R human adrenocortical 
carcinoma cell line treated with cod liver oil, a model to identify chemicals that may alter 
steroidogenesis. This nutritional supplement derived from the liver of cod fish, like many fish oils, 
contains high levels of omega-3 fatty acids, EPA and DHA.  
Montano et al. [41] showed that exposure to extracts from cod liver oil increased the synthesis of 
testosterone, progesterone, estradiol and cortisol in H295R cell line. Cod liver oil also increased the 
expression of many genes encoding proteins involved in steroidogenesis, such as the cytochrome P450 
family 1 subfamily A polypeptide 1 (CYP1A1), the melanocortin 2 receptor (MC2R), the steroidogenic 
acute regulatory protein (StAR), the cytochrome P450 family 11 subfamily B polypeptide 1 
(CYP11B1), the cytochrome P450 family 11 subfamily B polypeptide 2 (CYP11B2), the  
cytochrome P450 family 19 subfamily A polypeptide 1 (CYP19A1), the cytochrome P450 steroid  
17α-hydroxylase/17,20-lyase (CYP17A1), and the hydroxy-delta-5-steroid dehydrogenase 3 beta- and 
steroid delta-isomerase 2 (HSD3B2). A few of these genes play a key role in testosterone synthesis. 
StAR mediates the transfer of cholesterol from the outer mitochondrial membrane to the inner 
mitochondrial membrane. HSD3B2 is involved in the biosynthesis of all classes of hormonal steroids. 
The CYP17A1 gene, which is down-regulated, encodes the 17α-hydroxylase enzyme. 
Recently, it was observed in our laboratories [32] that CLA treatment (0–7.5 μM) increased the 
synthesis of testosterone in a rat Leydig tumor cell line (R2C), and release in the culture media. 
Testosterone secretion increased linearly with CLA concentration after 48 h from treatment. In the 
light of this result, we investigated the level of serum testosterone immediately after an acute bout 
resistance exercise after three weeks of CLA supplementation (6 g/day) in trained subjects. The blood 
level of total testosterone after CLA supplementation following the resistance exercise bout did not 
increase significantly as in vitro, although a small increase was observed. The limitation of this study 
was the doses used. In fact, for the in vivo experiments only one dose of CLA supplementation 
(previously reported in the literature [24]) was administered, while it is clear that different doses and 
dosages need to be tested to understand the effect of CLA on testosterone synthesis. 
Similar results were obtained in the ovarian tissue. It has been suggested that one of the 
mechanisms by which CLA may alter steroidogenesis may be by up- and down-regulating specific 
genes encoding for enzymes and transport proteins involved in the synthesis of prostaglandin and 
progesterone. In ovarian tissue, May et al. [42] showed that the mechanism whereby CLA improves 
steroidogenesis may be, in part, by decreasing prostagladin F2-α (PGF2α) synthesis in cultured bovine 
luteal cells through down-regulation of Cyclooxygenase-2 (COX-2) gene. No differences were 
observed in mRNA levels of StAR, P450scc and 3βHSD that play key roles in progesterone synthesis.  
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5. Cellular Mechanisms Responsible for the Effect of Testosterone on Skeletal Muscle and 
Physical Performance 
An important mechanism by which testosterone can increase the cross sectional area of the skeletal 
muscle fiber is the increase in the contractile protein synthesis while unaffecting protein breakdown [43]. 
The increase in fiber area (over 26%) is accompanied by a significant increase in the myonuclear 
number [44]. The major source for the addition of new myonuclei into hypertrophic muscle fibers is 
the satellite cells, which reside between the basal lamina and the sarcolemma of the muscle fiber [45]. 
The satellite cell pool, the number of resident satellite cells in the muscle, varies between individuals 
with different physical activity levels [46,47] and ages [48]. Moreover the satellite cell behavior 
(proliferation, differentiation or return to quiescence) can be affected by mechanical, local and 
systemic factors, such as testosterone [49]. In fact, satellite cells express androgen receptor, making the 
satellite cells a direct target for testosterone action [50]. Hence, another mechanism by which 
testosterone can induce skeletal muscle hypertrophy is by stimulating the activation of satellite cells [51] 
and promoting their entry into the cell cycle [52]. The cross-sectional area of a muscle (rather than 
volume or length) determines the amount of force it can generate by defining the number of 
sarcomeres which can operate in parallel.  
The effects of testosterone on human performance have been the objective of studies since the early 
1980s [53], but only in the last decade have more carefully designed studies been conducted, although 
all of these studies investigated the effect of exogenous testosterone [54]. It was demonstrated that 
supraphysiological doses of testosterone enhance maximal voluntary strength by increasing muscle mass 
and not by changing contractile properties, and the improvement in strength was dose-dependent [55]. 
Rogerson et al. [56] observed an increase in output of work and power during cycle sprinting in 
subjects integrated with testosterone. The data suggest that testosterone may increase sprinting 
performance in humans as in animals [57]. Moreover, testosterone may improve performance in sprint 
events by reducing reaction time, since it has been shown that testosterone regulates neuromuscular 
transmission in rats [58,59]. It has been hypothesized that testosterone may affect endurance 
performance since it induces an increase in hemoglobin concentration and hematocrit. This hypothesis 
was confirmed only in animals; in fact, exogenous testosterone increases endurance performance in 
rats [60], while in humans it does not improve performance [54]. The difference between species may 
be explained by the diversity in the relative proportion of type I fibers available for enhancement [61]. 
No changes in the ability of a muscle to continue in performing an exercise (fatigability) have been 
observed after testosterone use in humans [55]. 
6. Implications 
Testosterone is a steroid hormone with anabolic and anticatabolic effect on muscle tissues, playing 
a critical function for muscle gain and muscle performance of athletes [62,63]. It has been 
demonstrated that the acute increase in serum concentration of testosterone after resistance exercise 
depends on exercise program variables (intensity, volume, duration, rest, muscle mass trained) and 
individual characteristics (age, health, fitness level) [64,65], while it has been shown that moderately 
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prolonged endurance exercise induces an increase in the concentration of free testosterone mediated by 
a sympathetic stimulation of the testicles [66,67].  
Differently from fat supplements, the fat ingested with the daily diet may have the potential to alter 
the regulation and metabolism of testosterone in athletic men [68]. Volek et al. [68] showed that 
MUFA (mono-unsaturated fatty acid) and SFA (saturated fatty acid) were the strongest predictors of 
circulating testosterone in healthy athletic men during rest, while there was no significant correlation 
between PUFA and testosterone, there was a significant negative correlation between PUFA/SFA ratio 
and testosterone levels. The concept that high fat diets lead to alterations in serum level of testosterone 
of athletes, has been shown also by different research groups [69]. Taking into consideration the fact 
that athletes may experience a decline in testosterone concentrations due to overtraining and very low 
fat diets (this condition may be aggravated in athletes of specific sports, such as gymnasts, wrestlers 
and boxers), fish oil and CLA supplementation may be proposed to compensate the alteration in serum 
testosterone induced by prolonged and intense exercise training period (over training). These 
supplements may also promote an anabolic environment over a training program.  
On the other hand, fat supplement side-effects have never been demonstrated and documented. If 
fat supplements induce an increase in blood testosterone, this may have an effect on several other 
tissues, among which include stem or progenitor cells [70]. Testosterone has been reported to have a 
pro-survival and growth-stimulatory effect on mature progenitor cells [71] or a negative effect on the 
cardiovascular system down-regulating signal transducer and activator of transcription 3 (STAT3) and 
suppressor of cytokine signaling 3 (SOCS3) expression during acute ischemia and reperfusion [72]. 
Hence, indirectly, fat supplements may have an effect on cardiac progenitor cells which are 
fundamental during heart development [73,74], myocardium homeostasis and myocardium 
regeneration [75]. This consideration is very important taking into account that cardiovascular diseases 
are the leading causes of death among athletes [76]. 
Additional research on the effect of fish oil and CLA supplementation on enzymes leading to 
testosterone synthesis are important to clarify the molecular mechanisms by which fat supplements 
may contribute to increase the anabolic effect of exercise, and the side-effects of this kind  
of supplementation. 
Abbreviations 
CLA conjugated linoleic acid 
DHA docosahexaenoic acid 





RBC red blood cells 
PUFA polyunsaturated fatty acids 
P450ssc P450 side-chain cleavage enzyme 
3β-HSD 3β-hydroxysteroid dehydrogenase  
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P450c17 17α-hydroxylase/17,20-lyase 
17β-HSD 17β-hydroxysteroid dehydrogenase  
CYP17A1 cytochrome P450, steroid 17α-hydroxylase/17,20-lyase 
H295R human adrenocortical carcinoma cells 
PGF2α prostagladin F2-α  
MUFA mono-unsaturated fatty acid 
SFA saturated fatty acid 
CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1 
MC2R melanocortin 2 receptor 
StAR steroidogenic acute regulatory protein 
CYP11B1 cytochrome P450, family 11, subfamily B, polypeptide 1 
CYP11B2 cytochrome P450, family 11, subfamily B, polypeptide 2 
CYP19A1 cytochrome P450, family 19, subfamily A, polypeptide 1 
HSD3B2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 
STAT3 signal transducer and activator of transcription 3 
SOCS3 suppressor of cytokine signaling 3 
COX-2 cyclooxygenase-2 
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